The global ambulatory polysomnography (PSG) systems market is expected to enjoy a valuation of US$ 311.2 Million in the year 2022, and further expand at a CAGR rate of 5.2% to reach a valuation of US$ 516.9 Million by the year 2032. According to a recent study by Future Market Insights, up to 24 channel PSG systems in the product segment are leading the market with a share of about 37.0% in the year 2021, within the global market.
Market Outlook:
| Data Points | Market Insights |
|---|---|
| Market Value 2021 | US$ 298.7 Million |
| Market Value 2022 | US$ 311.2 Million |
| Market Value 2032 | US$ 516.9 Million |
| CAGR 2022 to 2032 | 5.2% |
| Market Share of Top 5 Countries | 57.2% |
| Key Market Players | Koninklijke Philips N.V., Natus Medical Incorporated, NIHON KOHDEN CORPORATION, Nox Medical, Löwenstein Medical Technology GmbH + Co. KG., Neurosoft, Cadwell Industries Inc., SOMNOmedics GmbH, Compumedics Limited, Neurovirtual / Sleepvirtual, Onera Technologies B.V., and Medicom MTD Ltd |
The growth of the ambulatory polysomnography (PSG) systems market is very much inclined to the prevalence of sleep disorders, which is constantly rising. This constant rise in the prevalence of various sleep disorders creates lucrative opportunities for the growth of the ambulatory polysomnography (PSG) systems market. A 2021 study published by The Millennial Sleep Lab found that the incidence of insomnia in USA military personnel rose from 6/10,000 in 2005 to 272/10,000 in 2019.
Moreover, the growing prevalence of sleep disorders in European countries such as Germany and the United Kingdom is expected to boost the adoption of ambulatory polysomnography (PSG) systems across Europe. Since the number of sleep disorder-related cases is rising consistently, the need for sleep disorder diagnosis is also increasing. Nowadays, the quality of diagnostics matters, and since ambulatory polysomnography (PSG) systems offer optimal comfort for patients, this increasing prevalence is linked with the growth of this market and is quite advantageous for the growth of the ambulatory polysomnography (PSG) systems market.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The market value of the ambulatory polysomnography (PSG) systems market was approximately 39.7% of the overall US$ 752.4 Million of the global polysomnography (PSG) systems market in 2021.
The sale of the ambulatory polysomnography (PSG) systems market expanded at a CAGR of 3.7% from 2015 to 2021. Disruptions in metabolism and/or sleep-wake cycles can occur due to excess weight or in other words, it is very common for an obese individual to encounter any of the sleep disorders. As per findings from the WHO European Regional Obesity Report 2022, almost 60% of adults and nearly one in every third child in the WHO European Region get affected by overweight and obesity.
As per this report, it is also suggested that obesity is linked with an increase in the risk of chronic respiratory diseases like obstructive sleep apnea (OSA) which is a highly prevalent sleep disorder, globally. Since obese individuals are prone to sleep disorders, this could have a positive impact on the sleep disorder diagnostics market. Because of the benefits offered by ambulatory polysomnography systems, these systems are in demand among the sufferers of various sleep disorders. This is driving the growth of the ambulatory polysomnography (PSG) systems market.
Other than this, technological advancements in the sleep care industry can be considered a recognizable driver for this market. With various innovative technologies like portable devices, smartphone applications, telehealth, etc., the ambulatory polysomnography (PSG) systems market is experiencing steady growth. Research and development have contributed to the development of wireless and portable polysomnography systems like the Nox A1s PSG from Nox Medical. Wireless capabilities provide comfort to the patients in terms of providing a sense of independence, because they can move freely throughout the night while they are in the process of diagnosis. This will impact the growth of the ambulatory polysomnography (PSG) systems market in a positive way.
Thus, owing to the forenamed factors, the global ambulatory polysomnography (PSG) systems market is expected to grow at a CAGR rate value of 5.2% during the forecast period from 2022 to 2032.
The market is set to have an assertive outlook, owing to the increased use of artificial intelligence in PSG systems. In sleep diagnostics, ambulatory PSG sleep studies are emerging as an effective diagnostic tool. Ambulatory PSG helps in conducting an overnight polysomnography study addressing the comfort of a patient in his or her home. It collects all the necessary data that is taken into consideration in reference to a proper sleep diagnostic study. These systems provide the flexibility of wireless and portable PSG systems, which enables sleep clinics to address more patients by transitioning the sleep studies from the laboratory to the home. Manufacturers are addressing the shift towards home-based sleep tests through the utilization of artificial intelligence in the field of sleep diagnostics. This can be considered an opportunistic factor for the growth of the ambulatory polysomnography (PSG) systems market.
Apart from this, there is significant scope for the growth of the ambulatory polysomnography (PSG) systems market because of the large undiagnosed population with respect to sleep apnea. As per one of the research papers published by the National Center for Biotechnology Information, sleep apnea is quite a common disorder in the USA and often goes undiagnosed. This factor is anticipated to drive the ambulatory polysomnography (PSG) systems market because of the advantages offered by this system in comparison to in-lab polysomnography systems.
Principal Consultant
The majority of the population, especially in rural regions, is not aware of the serious implications of sleep apnea. If sleep disorders are not treated, they can lead to chronic conditions such as heart failure, stroke, high blood pressure, diabetes, and obesity. This can further lead to severe health conditions such as uncontrolled blood pressure, heart attack, weakened and narrow blood vessels of kidneys, and aneurysms.
The lack of awareness about sleeping disorders in a significant chunk of the population is likely to hamper the growth of the ambulatory polysomnography (PSG) systems market in the near future.
The USA dominates the North American region with a total market share of about 90.8% in 2021, and a similar trend is expected over the forecast period.
According to the American Sleep Association, around 50-70 million adults in the USA were suffering from sleep apnea in 2021. Since the prevalence of sleep-related disorders is quite high in the USA, therefore the requirement for the diagnosis is also high. Ambulatory polysomnography systems offer the utmost comfort and convenience to patients, therefore the sales of ambulatory polysomnography (PSG) systems in the USA are quite high and are anticipated to grow moving forward.
Germany is set to exhibit a CAGR growth rate of nearly 6.7% in the European ambulatory polysomnography (PSG) systems market during the forecast period. In 2021, Germany held the highest market share of about 26.6% in the Europe ambulatory polysomnography (PSG) systems market.
The presence of multiple manufacturers like Löwenstein Medical Technology GmbH + Co. KG., Compumedics Limited, SOMNOmedics GmbH, and others is quite high in the German market and this has boosted the availability of ambulatory polysomnography (PSG) systems in Germany.
China held approximately 37.8% market share in the East Asia ambulatory polysomnography (PSG) systems market in 2021. It is projected to display growth at a lucrative CAGR rate of 5.7% during the forecast period.
Sleep disorders like obstructive sleep apnea are very common among people in China. As per one of the research papers published in 2022. Currently, there are around 176 million people suffering from obstructive sleep apnea in China. This points to the rising prevalence of sleep disorders in China and this scenario also contributes to the propelling growth of the ambulatory polysomnography (PSG) systems market in China.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Up to 24 channel PSG systems in the product category of the ambulatory polysomnography (PSG) systems market, hold a market share of about 37.0% in the global market in 2021. The number of products available in the range of up to 24 channel PSG systems is higher in comparison to the other product categories and therefore, this segment is dominant in the product category of the ambulatory polysomnography (PSG) systems market.
Obstructive sleep apnea accounted for a revenue share of 56.3% in 2021 and is expected to display gradual growth over the forecast period. The prevalence of obstructive sleep apnea is higher as compared to the other segments in the application category.
Sleep laboratories held the highest market share of 62.1% during the year 2021. The increasing number of clinics sleep clinics or laboratories in the field of sleep medicine is a major factor due to which the sleep laboratories have been estimated to account for more than half of the share of the end-user segment in the forecast period as well.
To strengthen their presence around the globe and improve their business strategies, the key players are involved in various product launches & approvals, expansions, collaborations, and partnerships. These are the key promotional strategies adopted by the key players in the ambulatory polysomnography (PSG) systems market.
| Attribute | Details |
|---|---|
| Forecast Period | 2022 to 2032 |
| Historical Data Available for | 2015 to 2021 |
| Market Analysis | US$ Million for Value |
| Key Regions Covered | North America, Latin America, Europe, South Asia, East Asia, Oceania, and Middle East & Africa |
| Key Countries Covered | USA, Canada, Brazil, Mexico, Argentina, Germany, Italy, France, United Kingdom, Spain, Russia, BENELUX, Nordic Countries, India, Malaysia, Thailand, Indonesia, China, Japan, South Korea, Australia, New Zealand, Turkey, GCC Countries, and South Africa |
| Key Market Segments Covered | Product, Application, End User, and Region |
| Key Companies Profiled |
|
| Pricing | Available upon Request |
The global ambulatory polysomnography (PSG) systems market is worth US$ 298.7 Million at present (2021).
The ambulatory polysomnography (PSG) systems market is expected to reach US$ 516.9 Million by end of 2032 at a CAGR of 5.2%.
Inclination towards wireless polysomnography, manufacturers’ focus on smaller and lighter systems, and the increasing emergence of ambulatory PSG are some of the key trends in this market.
North America dominated the global ambulatory polysomnography (PSG) systems market accounting for the highest market share of 38.5% in 2021
Germany displays a market share of around 26.6% in 2021 in the Europe ambulatory polysomnography (PSG) systems market and is set to present a lucrative CAGR growth rate of 6.7% during the forecasted years.
France accounts for about 17.5% of the market share of the Europe ambulatory polysomnography (PSG) systems market in 2021 and is projected to grow with a CAGR of 6.2% in the forecast period.
The USA, Germany, China, the United Kingdom, and France are the top five countries, which are expected to drive demand in the ambulatory polysomnography (PSG) systems market.
From 2015 to 2021, the market for ambulatory polysomnography (PSG) systems expanded at the rate of 3.7%.
China accounted for 37.8% market share of the East Asia ambulatory polysomnography (PSG) systems market in 2021. The ambulatory polysomnography (PSG) systems market in China is expected to grow at a 5.7% CAGR value during the forecast period.
United Kingdom held a market share of around 19.6% of the Europe ambulatory polysomnography (PSG) systems market in 2021 and is set to present a lucrative CAGR growth rate of 6.4% during the forecast period.
1. Executive Summary | Ambulatory Polysomnography (PSG) Systems Market 1.1. Global Market Outlook 1.2. Demand Side Trends 1.3. Supply Side Trends 1.4. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 2.3. Inclusions and Exclusions 3. Key Market Trends 3.1. Key Trends Impacting the Market 3.2. Product Innovation / Development Trends 4. Key Inclusions 4.1. Product Adoption / Usage Analysis 4.2. Product USPs / Features 4.3. Key Promotional Strategies Used by Manufacturers 4.4. Regulatory Scenario 4.5. PESTLE Analysis 4.6. Porter Analysis 5. Market Background 5.1. Macro-Economic Factors 5.1.1. Global GDP Growth Outlook 5.1.2. Global Healthcare Spending Outlook 5.2. Forecast Factors - Relevance & Impact 5.2.1. Historic Growth of Top Companies 5.2.2. Increasing Adoption of Advanced Technologies 5.2.3. Rising Ageing Population 5.2.4. Rising Prevalence of Sleep Disorders 5.2.5. New Product Approval and Launch 5.2.6. Cost of Ambulatory PolysoMillionography (PSG) Systems 5.2.7. Strategic Mergers and Acquisitions Among Key Players 5.2.8. Growing Investment in Healthcare Expenditure 5.3. Dynamics 5.3.1. Drivers 5.3.2. Restraints 5.3.3. Opportunity Analysis 6. COVID-19 Crisis - Impact Assessment 6.1. COVID-19 and Impact Analysis 6.1.1. By Product 6.1.2. By Application 6.1.3. By End User 6.1.4. By Region 6.2. COVID-19 Impact on the Market 7. Global Market Volume (in Units) Analysis 2015 to 2021 and Forecast, 2022 to 2032 7.1. Historical Volume (in Units) Analysis, 2015 to 2021 7.2. Current and Future Volume (in Units) Projections, 2022 to 2032 7.2.1. Y-o-Y Growth Trend Analysis 7.2.2. Absolute $ Opportunity Analysis 8. Global Market - Pricing Analysis 8.1. Regional Pricing Analysis By Product 8.2. Global Average Pricing Analysis Benchmark 9. Global Market Demand (in Value or Size in US$ Million) Analysis 2015 to 2021 and Forecast, 2022 to 2032 9.1. Historical Market Value (US$ Million) Analysis, 2015 to 2021 9.2. Current and Future Market Value (US$ Million) Projections, 2022 to 2032 9.2.1. Y-o-Y Growth Trend Analysis 9.2.2. Absolute $ Opportunity Analysis 10. Global Market Analysis 2015 to 2021 and Forecast 2022 to 2032, By Product 10.1. Introduction / Key Findings 10.2. Historical Market Size (US$ Million) and Volume (Units) Analysis, By Product, 2015 to 2021 10.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast, By Product, 2022 to 2032 10.3.1. Up-to 12 Channel PSG Systems 10.3.2. Up-to 24 Channel PSG Systems 10.3.3. Up-to 32 Channel PSG Systems 10.3.4. Above 32 Channel PSG Systems 10.4. Market Attractiveness Analysis, By Product 11. Global Market Analysis 2015 to 2021 and Forecast 2022 to 2032, By Application 11.1. Introduction / Key Findings 11.2. Historical Market Size (US$ Million) Analysis By Application, 2015 to 2021 11.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Application, 2022 to 2032 11.3.1. Obstructive Sleep Apnea 11.3.2. Narcolepsy 11.3.3. Chronic InsoMillionia 11.3.4. Others 11.4. Market Attractiveness Analysis, By Application 12. Global Market Analysis 2015 to 2021 and Forecast 2022 to 2032, by End User 12.1. Introduction / Key Findings 12.2. Historical Market Size (US$ Million) Analysis By End User, 2015 to 2021 12.3. Current and Future Market Size (US$ Million) Analysis and Forecast By End User, 2022 to 2032 12.3.1. Hospitals 12.3.2. Sleep Laboratories 12.3.3. Home Care Settings 12.4. Market Attractiveness Analysis By End User 13. Global Market Analysis 2015 to 2021 and Forecast 2022 to 2032, by Region 13.1. Introduction 13.2. Historical Market Size (US$ Million) Analysis By Region, 2015 to 2021 13.3. Current Market Size (US$ Million) Analysis and Forecast By Region, 2022 to 2032 13.3.1. North America 13.3.2. Latin America 13.3.3. Europe 13.3.4. South Asia 13.3.5. East Asia 13.3.6. Oceania 13.3.7. Middle East and Africa (MEA) 13.4. Market Attractiveness Analysis By Region 14. North America Market Analysis 2015 to 2021 and Forecast 2022 to 2032 14.1. Introduction 14.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2015 to 2021 14.3. Market Size (US$ Million) and Volume (Units) Forecast, By Market Taxonomy, 2022 to 2032 14.3.1. By Country 14.3.1.1. USA 14.3.1.2. Canada 14.3.2. By Product 14.3.3. By Application 14.3.4. By End User 14.4. Market Attractiveness Analysis 14.4.1. By Country 14.4.2. By Product 14.4.3. By Application 14.4.4. By End User 14.5. Key Market Participants - Intensity Mapping 14.6. Drivers and Restraints - Impact Analysis 14.7. Country-Level Analysis & Forecast 14.7.1. USA Market Analysis 14.7.1.1. Introduction 14.7.1.2. Market Analysis and Forecast by Market Taxonomy 14.7.1.2.1. By Product 14.7.1.2.2. By Application 14.7.1.2.3. By End User 14.7.2. Canada Market Analysis 14.7.2.1. Introduction 14.7.2.2. Market Analysis and Forecast by Market Taxonomy 14.7.2.2.1. By Product 14.7.2.2.2. By Application 14.7.2.2.3. By End User 15. Latin America Market Analysis 2015 to 2021 and Forecast 2022 to 2032 15.1. Introduction 15.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2015 to 2021 15.3. Market Size (US$ Million) and Volume (Units) Forecast, By Market Taxonomy, 2022 to 2032 15.3.1. By Country 15.3.1.1. Brazil 15.3.1.2. Mexico 15.3.1.3. Argentina 15.3.1.4. Rest of Latin America 15.3.2. By Product 15.3.3. By Application 15.3.4. By End User 15.4. Market Attractiveness Analysis 15.4.1. By Country 15.4.2. By Product 15.4.3. By Application 15.4.4. By End User 15.5. Key Market Participants - Intensity Mapping 15.6. Drivers and Restraints - Impact Analysis 15.7. Country-Level Analysis & Forecast 15.7.1. Brazil Market Analysis 15.7.1.1. Introduction 15.7.1.2. Market Analysis and Forecast by Market Taxonomy 15.7.1.2.1. By Product 15.7.1.2.2. By Application 15.7.1.2.3. By End User 15.7.2. Mexico Market Analysis 15.7.2.1. Introduction 15.7.2.2. Market Analysis and Forecast by Market Taxonomy 15.7.2.2.1. By Product 15.7.2.2.2. By Application 15.7.2.2.3. By End User 15.7.3. Argentina Market Analysis 15.7.3.1. Introduction 15.7.3.2. Market Analysis and Forecast by Market Taxonomy 15.7.3.2.1. By Product 15.7.3.2.2. By Application 15.7.3.2.3. By End User 16. Europe Market Analysis 2015 to 2021 and Forecast 2022 to 2032 16.1. Introduction 16.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2015 to 2021 16.3. Market Size (US$ Million) and Volume (Units) Forecast, By Market Taxonomy, 2022 to 2032 16.3.1. By Country 16.3.1.1. Germany 16.3.1.2. Italy 16.3.1.3. France 16.3.1.4. United Kingdom 16.3.1.5. Spain 16.3.1.6. Russia 16.3.1.7. BENELUX 16.3.1.8. Nordic Countries 16.3.1.9. Rest of Europe 16.3.2. By Product 16.3.3. By Application 16.3.4. By End User 16.4. Market Attractiveness Analysis 16.4.1. By Country 16.4.2. By Product 16.4.3. By Application 16.4.4. By End User 16.5. Key Market Participants - Intensity Mapping 16.6. Drivers and Restraints - Impact Analysis 16.7. Country-Level Analysis & Forecast 16.7.1. Germany Market Analysis 16.7.1.1. Introduction 16.7.1.2. Market Analysis and Forecast by Market Taxonomy 16.7.1.2.1. By Product 16.7.1.2.2. By Application 16.7.1.2.3. By End User 16.7.2. Italy Market Analysis 16.7.2.1. Introduction 16.7.2.2. Market Analysis and Forecast by Market Taxonomy 16.7.2.2.1. By Product 16.7.2.2.2. By Application 16.7.2.2.3. By End User 16.7.3. France Market Analysis 16.7.3.1. Introduction 16.7.3.2. Market Analysis and Forecast by Market Taxonomy 16.7.3.2.1. By Product 16.7.3.2.2. By Application 16.7.3.2.3. By End User 16.7.4. United Kingdom Market Analysis 16.7.4.1. Introduction 16.7.4.2. Market Analysis and Forecast by Market Taxonomy 16.7.4.2.1. By Product 16.7.4.2.2. By Application 16.7.4.2.3. By End User 16.7.5. Spain Market Analysis 16.7.5.1. Introduction 16.7.5.2. Market Analysis and Forecast by Market Taxonomy 16.7.5.2.1. By Product 16.7.5.2.2. By Application 16.7.5.2.3. By End User 16.7.6. Russia Market Analysis 16.7.6.1. Introduction 16.7.6.2. Market Analysis and Forecast by Market Taxonomy 16.7.6.2.1. By Product 16.7.6.2.2. By Application 16.7.6.2.3. By End User 16.7.7. BENELUX Market Analysis 16.7.7.1. Introduction 16.7.7.2. Market Analysis and Forecast by Market Taxonomy 16.7.7.2.1. By Product 16.7.7.2.2. By Application 16.7.7.2.3. By End User 16.7.8. Nordic Countries Market Analysis 16.7.8.1. Introduction 16.7.8.2. Market Analysis and Forecast by Market Taxonomy 16.7.8.2.1. By Product 16.7.8.2.2. By Application 16.7.8.2.3. By End User 17. South Asia Market Analysis 2015 to 2021 and Forecast 2022 to 2032 17.1. Introduction 17.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2015 to 2021 17.3. Market Size (US$ Million) and Volume (Units) Forecast, By Market Taxonomy, 2022 to 2032 17.3.1. By Country 17.3.1.1. India 17.3.1.2. Malaysia 17.3.1.3. Thailand 17.3.1.4. Indonesia 17.3.1.5. Rest of South Asia 17.3.2. By Product 17.3.3. By Application 17.3.4. By End User 17.4. Market Attractiveness Analysis 17.4.1. By Country 17.4.2. By Product 17.4.3. By Application 17.4.4. By End User 17.5. Key Market Participants - Intensity Mapping 17.6. Drivers and Restraints - Impact Analysis 17.7. Country-Level Analysis & Forecast 17.7.1. India Market Analysis 17.7.1.1. Introduction 17.7.1.2. Market Analysis and Forecast by Market Taxonomy 17.7.1.2.1. By Product 17.7.1.2.2. By Application 17.7.1.2.3. By End User 17.7.2. Malaysia Market Analysis 17.7.2.1. Introduction 17.7.2.2. Market Analysis and Forecast by Market Taxonomy 17.7.2.2.1. By Product 17.7.2.2.2. By Application 17.7.2.2.3. By End User 17.7.3. Thailand Market Analysis 17.7.3.1. Introduction 17.7.3.2. Market Analysis and Forecast by Market Taxonomy 17.7.3.2.1. By Product 17.7.3.2.2. By Application 17.7.3.2.3. By End User 17.7.4. Indonesia Market Analysis 17.7.4.1. Introduction 17.7.4.2. Market Analysis and Forecast by Market Taxonomy 17.7.4.2.1. By Product 17.7.4.2.2. By Application 17.7.4.2.3. By End User 18. East Asia Market Analysis 2015 to 2021 and Forecast 2022 to 2032 18.1. Introduction 18.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2015 to 2021 18.3. Market Size (US$ Million) and Volume (Units) Forecast, By Market Taxonomy, 2022 to 2032 18.3.1. By Country 18.3.1.1. China 18.3.1.2. Japan 18.3.1.3. South Korea 18.3.2. By Product 18.3.3. By Application 18.3.4. By End User 18.4. Market Attractiveness Analysis 18.4.1. By Country 18.4.2. By Product 18.4.3. By Application 18.4.4. By End User 18.5. Key Market Participants - Intensity Mapping 18.6. Drivers and Restraints - Impact Analysis 18.7. Country-Level Analysis & Forecast 18.7.1. China Market Analysis 18.7.1.1. Introduction 18.7.1.2. Market Analysis and Forecast by Market Taxonomy 18.7.1.2.1. By Product 18.7.1.2.2. By Application 18.7.1.2.3. By End User 18.7.2. Japan Market Analysis 18.7.2.1. Introduction 18.7.2.2. Market Analysis and Forecast by Market Taxonomy 18.7.2.2.1. By Product 18.7.2.2.2. By Application 18.7.2.2.3. By End User 18.7.3. South Korea Market Analysis 18.7.3.1. Introduction 18.7.3.2. Market Analysis and Forecast by Market Taxonomy 18.7.3.2.1. By Product 18.7.3.2.2. By Application 18.7.3.2.3. By End User 19. Oceania Market Analysis 2015 to 2021 and Forecast 2022 to 2032 19.1. Introduction 19.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2015 to 2021 19.3. Market Size (US$ Million) and Volume (Units) Forecast, By Market Taxonomy, 2022 to 2032 19.3.1. By Country 19.3.1.1. Australia 19.3.1.2. New Zealand 19.3.2. By Product 19.3.3. By Application 19.3.4. By End User 19.4. Market Attractiveness Analysis 19.4.1. By Country 19.4.2. By Product 19.4.3. By Application 19.4.4. By End User 19.5. Key Market Participants - Intensity Mapping 19.6. Drivers and Restraints - Impact Analysis 19.7. Country-Level Analysis & Forecast 19.7.1. Australia Market Analysis 19.7.1.1. Introduction 19.7.1.2. Market Analysis and Forecast by Market Taxonomy 19.7.1.2.1. By Product 19.7.1.2.2. By Application 19.7.1.2.3. By End User 19.7.2. New Zealand Market Analysis 19.7.2.1. Introduction 19.7.2.2. Market Analysis and Forecast by Market Taxonomy 19.7.2.2.1. By Product 19.7.2.2.2. By Application 19.7.2.2.3. By End User 20. Middle East and Africa (MEA) Market Analysis 2015 to 2021 and Forecast 2022 to 2032 20.1. Introduction 20.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2015 to 2021 20.3. Market Size (US$ Million) and Volume (Units) Forecast, By Market Taxonomy, 2022 to 2032 20.3.1. By Country 20.3.1.1. Turkey 20.3.1.2. GCC Countries 20.3.1.3. South Africa 20.3.1.4. Rest of Middle East and Africa(MEA) 20.3.2. By Product 20.3.3. By Application 20.3.4. By End User 20.4. Market Attractiveness Analysis 20.4.1. By Country 20.4.2. By Product 20.4.3. By Application 20.4.4. By End User 20.5. Key Market Participants - Intensity Mapping 20.6. Drivers and Restraints - Impact Analysis 20.7. Country-Level Analysis & Forecast 20.7.1. Turkey Market Analysis 20.7.1.1. Introduction 20.7.1.2. Market Analysis and Forecast by Market Taxonomy 20.7.1.2.1. By Product 20.7.1.2.2. By Application 20.7.1.2.3. By End User 20.7.2. GCC Countries Market Analysis 20.7.2.1. Introduction 20.7.2.2. Market Analysis and Forecast by Market Taxonomy 20.7.2.2.1. By Product 20.7.2.2.2. By Application 20.7.2.2.3. By End User 20.7.3. South Africa Market Analysis 20.7.3.1. Introduction 20.7.3.2. Market Analysis and Forecast by Market Taxonomy 20.7.3.2.1. By Product 20.7.3.2.2. By Application 20.7.3.2.3. By End User 21. Market Structure Analysis 21.1. Market Analysis by Tier of Companies 21.2. Market Share Analysis of Top Players 21.3. Market Presence Analysis 22. Competition Analysis 22.1. Competition Dashboard 22.2. Competition Benchmarking 22.3. Competition Deep Dive 22.3.1. Koninklijke Philips N.V. 22.3.1.1. Overview 22.3.1.2. Product Portfolio 22.3.1.3. Profitability by Market Segments (Product/Region) 22.3.1.4. Sales Footprint 22.3.1.5. Strategy Overview 22.3.2. Natus Medical Incorporated 22.3.2.1. Overview 22.3.2.2. Product Portfolio 22.3.2.3. Profitability by Market Segments (Product/Region) 22.3.2.4. Sales Footprint 22.3.2.5. Strategy Overview 22.3.3. NIHON KOHDEN CORPORATION 22.3.3.1. Overview 22.3.3.2. Product Portfolio 22.3.3.3. Profitability by Market Segments (Product/Region) 22.3.3.4. Sales Footprint 22.3.3.5. Strategy Overview 22.3.4. Nox Medical 22.3.4.1. Overview 22.3.4.2. Product Portfolio 22.3.4.3. Profitability by Market Segments (Product/Region) 22.3.4.4. Sales Footprint 22.3.4.5. Strategy Overview 22.3.5. Löwenstein Medical Technology GmbH + Co. KG. 22.3.5.1. Overview 22.3.5.2. Product Portfolio 22.3.5.3. Profitability by Market Segments (Product/Region) 22.3.5.4. Sales Footprint 22.3.5.5. Strategy Overview 22.3.6. Neurosoft 22.3.6.1. Overview 22.3.6.2. Product Portfolio 22.3.6.3. Profitability by Market Segments (Product/Region) 22.3.6.4. Sales Footprint 22.3.6.5. Strategy Overview 22.3.7. Cadwell Industries Inc. 22.3.7.1. Overview 22.3.7.2. Product Portfolio 22.3.7.3. Profitability by Market Segments (Product/Region) 22.3.7.4. Sales Footprint 22.3.7.5. Strategy Overview 22.3.8. SOMillionOmedics GmbH 22.3.8.1. Overview 22.3.8.2. Product Portfolio 22.3.8.3. Profitability by Market Segments (Product/Region) 22.3.8.4. Sales Footprint 22.3.8.5. Strategy Overview 22.3.9. Compumedics Limited 22.3.9.1. Overview 22.3.9.2. Product Portfolio 22.3.9.3. Profitability by Market Segments (Product/Region) 22.3.9.4. Sales Footprint 22.3.9.5. Strategy Overview 22.3.10. Neurovirtual / Sleepvirtual 22.3.10.1. Overview 22.3.10.2. Product Portfolio 22.3.10.3. Profitability by Market Segments (Product/Region) 22.3.10.4. Sales Footprint 22.3.10.5. Strategy Overview 22.3.11. Onera Technologies B.V 22.3.11.1. Overview 22.3.11.2. Product Portfolio 22.3.11.3. Profitability by Market Segments (Product/Region) 22.3.11.4. Sales Footprint 22.3.11.5. Strategy Overview 22.3.12. Medicom MTD Ltd 22.3.12.1. Overview 22.3.12.2. Product Portfolio 22.3.12.3. Profitability by Market Segments (Product/Region) 22.3.12.4. Sales Footprint 22.3.12.5. Strategy Overview 23. Assumptions and Acronyms Used 24. Research Methodology
Explore Healthcare Insights
View Reports
Ambulatory Polysomnography (PSG) Systems Market
